Tonix Pharmaceuticals Holding Corp. · NASDAQ:TNXP
Saenger Bradley reported 1 trade in Tonix Pharmaceuticals Holding Corp. shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 9, 2026
On Jun 30, 2026, Saenger Bradley (Chief Financial Officer) reported 1 trade in Tonix Pharmaceuticals Holding Corp. shares at US$10.91 for US$15,852, leaving 2,154 shares. Filed Jul 9, 2026 (Form 4).
- Shares
- 1,453 shares
- Price
- US$10.91
- Value
- US$15,852
- Holding after
- 2,154 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock, $0.001 par value | Other | 1,453 | US$10.91 | 2,154 | Direct |
Source
Related
- Tonix Pharmaceuticals Holding Corp.
- Saenger Bradley
- Tonix Pharmaceuticals Holding Corp. shareholders
- Form 4 · Lederman Seth · Aug 31, 2026
- Form 4 · Bagger Richard H · Aug 24, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · AQR Capital Management LLC · Aug 13, 2026
- Form 4 · Taylor Carolyn E. · Jun 15, 2026